| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/07/2003 | US20030148329 Variants of alpha-fetoprotein coding and expression sequences |
| 08/07/2003 | US20030148327 Nucleic acid of given sequence; oligonucleotides and oligomers for detecting the cytosine methylation of genes; tumors and cancer |
| 08/07/2003 | US20030148326 Diagnosis of diseases associated with dna transcription |
| 08/07/2003 | US20030148325 Infectious clones |
| 08/07/2003 | US20030148324 Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides |
| 08/07/2003 | US20030148322 Control of TGFbeta signaling by km23 superfamily members |
| 08/07/2003 | US20030148320 Of given sequence; has promoter activity thus enabling genetic manipulation |
| 08/07/2003 | US20030148317 Isolated polypeptide of given sequence; use in differentiation of monocytes and as a anti-proliferative agent for lung tumor cells |
| 08/07/2003 | US20030148315 Increases complementarity in a heteroduplex polynucleotide sequence |
| 08/07/2003 | US20030148314 Isolated nucleic acid of given sequence; diagnosis by measuring level of expression of marker proteins |
| 08/07/2003 | US20030148312 Measuring the expression level of MAL gene; atopic dermatitis and bronchial asthma |
| 08/07/2003 | US20030148309 For enhanced recombinogenicity, genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 08/07/2003 | US20030148305 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 08/07/2003 | US20030148300 Encoded by nucleic acid molecule of given sequence; use in producing transgenic plants with increased levels of tocopherol |
| 08/07/2003 | US20030148294 DNA encoding novel chemokine receptors |
| 08/07/2003 | US20030148285 Source of Immunodominant MHC-associated Peptides (SIMP); antibodies, probes, and cells, to characterize SIMP, modulate its cellular levels, diagnose and treat cancers and modulate immune response |
| 08/07/2003 | US20030148281 Nucleic acids encoding novel G-protein coupled receptors; use diagnosing or treating cancer, bone disorders, leukemia, cardiovascular disorders, brain disorders and hormonal disorders |
| 08/07/2003 | US20030148270 Genes from the 20q13 amplicon and their uses |
| 08/07/2003 | US20030148266 Use in diagnostic methods and as immunogens |
| 08/07/2003 | US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents |
| 08/07/2003 | US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions |
| 08/07/2003 | US20030148262 Chimeric alphavirus replicon particles |
| 08/07/2003 | US20030148261 Compositions and methods comprising West Nile virus polypeptides |
| 08/07/2003 | US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/07/2003 | US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 08/07/2003 | US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids |
| 08/07/2003 | US20030147918 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 08/07/2003 | US20030147917 Retrovirus from the HIV group and its use |
| 08/07/2003 | US20030147916 Recombinant influenza a viruses |
| 08/07/2003 | US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/07/2003 | US20030147913 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family |
| 08/07/2003 | US20030147912 Use generating immunity to human immunodeficiency virus-1 (HIV); also gene therapy for neurodegenerative disorders; AAV inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein and regulatory sequences |
| 08/07/2003 | US20030147911 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 08/07/2003 | US20030147910 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 08/07/2003 | US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture |
| 08/07/2003 | US20030147908 Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins |
| 08/07/2003 | US20030147905 Administering an oligopeptide for immunotherapy |
| 08/07/2003 | US20030147904 Novel 13-transmembrane protein expressed in prostate cancer |
| 08/07/2003 | US20030147903 ABC transport polynucleotides, polypeptides and antibodies |
| 08/07/2003 | US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens |
| 08/07/2003 | US20030147901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/07/2003 | US20030147900 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes there of |
| 08/07/2003 | US20030147897 M. tuberculosis antigens |
| 08/07/2003 | US20030147895 Constructs for delivery of threrapeutic agents to neuronal cells |
| 08/07/2003 | US20030147893 Novel human transmembrane 4 superfamily protein |
| 08/07/2003 | US20030147892 Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides |
| 08/07/2003 | US20030147891 Administering to a human patient at least one anti-TNF(tumor necrosis factor) monoclonal antibody, or a TNF binding fragment for treating neurodegenerative diseases |
| 08/07/2003 | US20030147888 Polyvalent immunogen |
| 08/07/2003 | US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 08/07/2003 | US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 08/07/2003 | US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy |
| 08/07/2003 | US20030147868 A gene therapy, transfecting cells with exogenous genetic DNA for coding a desired therapeutic proteins, culturing the cells, for large-scale protein production |
| 08/07/2003 | US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same |
| 08/07/2003 | US20030147862 Administering a colony stimulating factor and/or a nucleic acids encoding the factor; treating a vascular tumor |
| 08/07/2003 | US20030147855 Using a recombinant adeno-associated virus (rAAV) vector; useful for treating obesity and diabetes |
| 08/07/2003 | US20030147853 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 08/07/2003 | US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/07/2003 | US20030147851 Polypeptides and fusion proteins, useful as anticarcinogenic agent |
| 08/07/2003 | US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells |
| 08/07/2003 | US20030147846 Methods of using macrophage inflammatory protein-4 (MIP-4) and myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides |
| 08/07/2003 | US20030147831 Hair follicle growth |
| 08/07/2003 | US20030147808 Single Chain Fv constructs of anti-ganglioside GD2 antibodies |
| 08/07/2003 | US20030147806 PSCA: prostate stem cell anitgen and uses thereof |
| 08/07/2003 | CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | CA2509776A1 Vaccine adjuvant based on a cd40 ligand |
| 08/07/2003 | CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 08/07/2003 | CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
| 08/07/2003 | CA2474723A1 Bioactive keratin peptides |
| 08/07/2003 | CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/07/2003 | CA2474590A1 Treatment of male sexual dysfunction |
| 08/07/2003 | CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them |
| 08/07/2003 | CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 08/07/2003 | CA2474316A1 Kappa-pviia-related conotoxins as organ protectants |
| 08/07/2003 | CA2474240A1 Novel monoclonal antibody and nematode larval antigens |
| 08/07/2003 | CA2473994A1 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 08/07/2003 | CA2473987A1 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 08/07/2003 | CA2473810A1 Fgfr agonists |
| 08/07/2003 | CA2469738A1 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 08/07/2003 | CA2465265A1 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 08/07/2003 | CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 08/07/2003 | CA2464138A1 Methods of preventing and treating flavivirus infection in animals |
| 08/07/2003 | CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | CA2463000A1 Vesicle-associated proteins |
| 08/07/2003 | CA2438112A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 08/06/2003 | EP1333278A1 Methods for monitoring and prognosis of disease course of gastrointestinal tumors |
| 08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
| 08/06/2003 | EP1333093A2 Human muscle nad: arginine adpribosyltransferase |
| 08/06/2003 | EP1333092A2 28 human secreted proteins |
| 08/06/2003 | EP1333091A1 Novel disease-associated gene and use thereof |
| 08/06/2003 | EP1333088A1 Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 08/06/2003 | EP1333036A1 Peg-modified erythropoietin |
| 08/06/2003 | EP1333035A2 Growth differentiation factor-8 |
| 08/06/2003 | EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR) |
| 08/06/2003 | EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 08/06/2003 | EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 08/06/2003 | EP1332369A1 Detection of infectious agents using antigen mimics |
| 08/06/2003 | EP1332227A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 08/06/2003 | EP1332224A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 08/06/2003 | EP1332215A2 Regulation of human secretin receptor-like gpcr |